About us
Mölnlycke at a glance
A world-leading MedTech company
Mölnlycke has been at the forefront of change since 1849, pioneering radical innovation that improves the quality of life for patients and those who care for them, while reducing the environmental impact of healthcare. We provide effective solutions and we’re always on the lookout for new ways to improve. Focusing on wound care and surgical procedures, Mölnlycke is organised around four Business Areas: Wound care, Operating room solutions, Gloves and Antiseptics.
-
Our purpose
Our purpose is to revolutionise care for people and planet. We drive change that improves the health and wellbeing of patients and those who care for them – while reducing the environmental footprint of healthcare.
Read more about our purpose -
Our strategy
Mölnlycke aims to become the market leader across all segments and geographies where the company operates. This ambition is firmly grounded in a strong portfolio of brands, as well as strong heritage of customer-insight driven innovations that improve the lives of people and planet.
Read more about our strategy
A strategic priority
We care about sustainability
Sustainability is a strategic priority at Mölnlycke and WeCare is our sustainability roadmap for 2030. It means creating shared value for all our stakeholders. It is a driver for growth, innovation and productivity and an essential part of our employee value proposition.
Latest news
-
Mölnlycke launches Biogel® Radiation Protection® gloves to tackle low adoption of hand protection in radiation-guided surgical procedures
Clinicians’ hands can receive up to 1,000 times more radiation than other parts of the body during image-guided procedures1; yet, radiation-attenuating gloves are used in only 10% of applicable cases2, putting healthcare professionals at risk of the damaging effects of radiation.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
-
Mölnlycke Recognized with Cardinal Health 2026 Rising Star Award
Mölnlycke Health Care has been honored with the Cardinal Health 2026 Rising Star Award, recognizing outstanding performance as a new member of the Cardinal Health Performance Plus Program.The award was presented during Cardinal Health's National Sales Meeting, held the week of August 9th, and reflects the strength of the partnership between the two organizations across Advanced Wound Care, Patient Positioning, and Antiseptics.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
Mölnlycke Health Care accelerates U.S. growth journey with three wound care product launches
Peachtree Corners, GA. July 7, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
-
Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.